THE AMERICAN SOCIETY of Hematology (ASH) has established the ASH Research Collaborative, a mission-focused nonprofit organization that will foster collaborative partnerships to accelerate progress in hematology with the goal of improving the lives of people affected by blood diseases.
Alexis Thompson, MD, MPH
“The launch of ASH Research Collaborative is a turning point in ASH’s mission to conquer blood diseases. It is a bold step by the Society to create a separate entity that can focus solely on these robust initiatives,” said ASH President Alexis Thompson, MD, MPH, of the Ann & Robert H. Lurie Children’s Hospital of Chicago. “ASH is uniquely positioned as a trusted convener to facilitate collaboration among various stakeholders for real scientific and clinical impact.”
At the core of the ASH Research Collaborative is its data hub, a technology platform that facilitates the exchange of information by aggregating research-grade data on hematologic diseases in a central place for the purposes of scientific inquiry and improved clinical care. With the core data collection infrastructure now in place, the ASH Research Collaborative is soliciting initial data contributors for the first two diseases—multiple myeloma and sickle cell disease. It is anticipated that additional diseases will be added in the future.
Clinical research sites interested in joining the Collaborative can now submit a letter of intent through the end of January 2019. ■
